Abstract:Objective:To investigate the treatment and prognosis of children with propionic acidemia (PA).Methods:This study involved 82 children with PA treated in the Department of Pediatric Endocrinol-ogy and Genetic Metabolism, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine from December 2002 to June 2020. Clinical data, including manifestations, laboratory test results, treatment strategy, and follow-up data, were summarized and analyzed using t-test or Mann-Whitney U test. Results:(1) Among the 82 cases consisting of 50 (61.0%) boys and 32 (39.0%) girls, 59 (72.0%) were diagnosed after clinical onset; 22 (26.8%) were diagnosed by newborn screening, including eight asymptomatic ones; the other one (1.2%) was asymptomatic but confirmed after the diagnosis of PA in the patient's sibling. The average age at first onset was 4.5 months (2 d-5 years) in 73 subjects, of which 28 (38.4%) were early-onset PA (within three months after birth). (2) Cranial MRI was performed on 26 cases, and abnormality was identified in 19 (73.1%) cases. (3) Hyperlactatemia was found in 16 cases among 30(53.3%) who underwent relevant examination with the average lactic acid level of 3.5 (2.1-4.3) μmol/L, while 35 out of 40 patients (87.5%) had hyperammonemia with an average blood ammonia level of 105.4 (34-907) μmol/L. (4) Among the 28 early-onset PA cases, 16 (57.1%) died, and 12 (42.9%) survived. There was no significant difference in the serum propionylcarnitine level, propionylcarnitine to acetylcarnitine ratio, urine 3-hydroxypropionic acid, or methylcitrate level between the survival and death cases. (5) Genetic mutations were detected in 75 patients (91.5%), among which 26 (34.7%) carried PCCA gene mutations and 48 (64%) with PCCB gene mutations. One patient (1.3%) harbored one known pathogenic mutation in each of the PCCA and PCCB genes. All mutations were inherited from the parents. (6) Followed up to June 2020, 57 (69.5%) patients survived, and 25 (30.5%) died from multiple organ failure secondary to severe acidosis, including 16 early-onset and nine late-onset cases. Conclusions:The primary treatment of PA is dietary control. Most PA patients are diagnosed after clinical onset, but symptoms may recur and even have developmental retardation despite treatment. Some of those diagnosed through newborn screening are asymptomatic after treatment. Newborn screening using tandem mass spectrometry is recommended for early diagnosis and treatment of PA.

Novel Variants of the PCCB Gene in Chinese Patients with Propionic Acidemia.

Gene mutation analysis in patients with propionic acidemia]

Novel Compound Heterozygous of PARKIN Causes Early-Onset Parkinson's Disease

Gene mutation analysis in pafients with propionic acidemia

Analysis of the relationship between phenotypes and genotypes in 60 Chinese patients with propionic acidemia: a fourteen-year experience at a tertiary hospital

Two Frequent Mutations Associated with the Classic Form of Propionic Acidemia in Taiwan

Combinations of exonic deletions and rare mutations lead to misdiagnosis of propionic acidemia

Identification and characterization of the largest deletion in the PCCA gene causing severe acute early-onset form of propionic acidemia

Biochemical and genetic approaches to the prenatal diagnosis of propionic acidemia in 78 pregnancies

Treatment and follow-up of 82 children with propionic acidemia

Natural history of propionic acidemia in the Amish population

Propionic acidemia in mice: Liver acyl-CoA levels and clinical course

Molecular investigation in Chinese patients with primary carnitine deficiency

Clinical features and CPS1 variants in Chinese patients with carbamoyl phosphate synthetase 1 deficiency

The attenuated hepatic clearance of propionate increases cardiac oxidative stress in propionic acidemia

Establishment of a non-integrated iPSC line (SDQLCHi043-A) from a male infant with propionic acidemia carrying compound heterozygote mutations in PCCB gene

Cross-Ethnic Variant Screening and Burden Analysis of PTPA in Parkinson's Disease.

A large deletion of PROP1 gene in patients with combined pituitary hormone deficiency from two unrelated Chinese pedigrees.

Identification and characterization of a new variation in DPM2 gene in two Chinese siblings with mild intellectual impairment

[Clinical Features and Genetic Analysis of a Child with 3-Methylglutenedioic Aciduria Type VII Due to Novel Variants of CLPB Gene].

Identification of Novel Variations of Oculocutaneous Albinism Type 2 with Prader–Willi Syndrome/angelman Syndrome in Two Chinese Families